Search
for
Sort by
Research 181–210 of 1000+
- Pathogenic Mechanisms and Mechanism‐Directed Therapies for Androgenetic Alopecia: Current Understanding and Future Directions
- Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review
- Testosterone Metabolism in the Skin
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Different patterns of 5α-reductase expression, cellular distribution, and testosterone metabolism in human follicular dermal papilla cells
- Testosterone Metabolism in Human Skin Cells in vitro and Its Interaction with Estradiol and Dutasteride
- Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis
- 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis
- Metabolic syndrome and dermatological diseases: association and treatment
- The eye and the skin in endocrine metabolic diseases
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- Anabolic and Metabolic Effects of Testosterone and Other Androgens: Direct Effects and Role of Testosterone Metabolic Products
- Role of prostaglandins in androgenetic alopecia
- From male PCOS to male endocrine-metabolic syndrome: a gender-neutral hypothesis
- Comprehensive Strategies for the Management of Androgenetic Alopecia: From Conventional Therapies to Nanotechnology and Regenerative Approaches
- Dyslipidemia, hormonal profiles, and sleep characteristics in men with androgenetic alopecia: an analysis based on data from the EPISONO study
- Lymphatic remodeling and metabolic rescue by VEGFR-3/DHA-coordinated microneedles for hair regeneration
- Integrative Proteo‐Transcriptomic Characterization of Androgenetic Alopecia Identifying ME1‐Mediated PPAR Signaling as a Potential Mediator
- Serum lipidomic changes and sex differences in androgenetic alopecia
- 1394 Long non-coding RNA AL136131.3 inhibits hair growth through mediating glycolysis in androgenetic alopecia
- 072 Covid-19 and male androgenetic alopecia: Systematic investigation of a potential epidemiological and genetic association
- Beyond Hirsutism: Hair Phenotypes as Clinical Signals for the Recognition of Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Scoping Review Protocol
- Assessment of retinol-binding protein 4 in patients with alopecia areata and androgenetic alopecia
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Metabolic syndrome and skin: Psoriasis and beyond
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Metabolic Syndrome and Skin Diseases